
Three little letters that could help transform the Irish economy: PhD
A quiet but important transformation is already under way. Census 2022 showed more than 38,000 people in the Republic held a doctoral degree, up 74 per cent since 2011.
In 2022, PhD enrolments increased by 5 per cent compared to the previous academic year, and 26 per cent since 2016. These numbers tell a story of progress, but they also hint at an untapped opportunity.
We need to build a culture in this State that sees the pursuit of a PhD not as a curiosity or a niche calling, but as a viable path for individuals and our national economy.
READ MORE
Too often, PhD students are imagined as solitary figures in lab coats, fiddling with beakers or analysing arcane data, locked away for years at university, while their peers begin to climb the corporate ladder.
The reality is far more exciting. Today's PhD graduates are fuelling the stburgeoning innovation ecosystem. They are solving real-world problems in industry, public policy, climate, and health. Unlocking a vast array of opportunities in emerging fields such as artificial intelligence. They are exactly the kind of minds we need to compete globally.
In a time of geopolitical uncertainty and economic upheaval, with US tariffs looming and their retreat from international scientific leadership, the State stands at a crossroads. As America turns inward, we have an opportunity to turn outward, to become a global hub for ideas. And ideas, as the economist Daniel Susskind puts it in his recent book, Growth: A Reckoning
,
are what power modern economies.
They can be reused and built upon without running out. It's these endlessly reusable ideas that have driven human progress and economic growth, and they come not from thin air, but from research, education, and, yes, from PhDs.
PhDs are the machines that generate ideas.
Patrick Guilbaud on bringing fine dining to Ireland, retirement plans, and not getting that third Michelin star
Listen |
47:51
But these ideas don't live in academic journals or university libraries alone. PhD researchers increasingly bring their skills into the heart of industry, working in R&D departments of leading companies, driving innovation, product development, and long-term strategic thinking. More than half of full-time researchers in the EU now work in the business sector.
Companies understand the value of this work. Take Apple, which spends more on research and development (R&D) in a year than the entire United Kingdom government. That's a recognition that investing in knowledge, creativity, and experimentation pays dividends in future products, competitiveness, and growth.
The International Monetary Fund 2024 Fiscal Monitor states that increasing R&D support by 0.5 percentage points of gross domestic product (GDP) annually, or about 50 per cent more than the current level in Organisation for Economic Co-operation and Development economies, could raise GDP by up to 2 per cent, and reduce a country's debt-to-GDP ratio for an average advanced economy over the following eight years.
That is a powerful return on investment, and one that starts with people. When we support PhDs, we're laying the groundwork for a more innovative, resilient Irish economy.
However, we are entering a more fragmented global economy, with rising protectionism, trade tensions, and tariffs. History shows that these kinds of measures often lead to a decline in international competition. When competition drops, so too does the incentive to innovate.
That's the danger for the Republic. A fall in global competition could trigger a slowdown in R&D investment here. This could create a ripple effect, dragging down productivity, increasing costs for Irish firms, and weakening the innovation spillovers we benefit from by being plugged into a competitive, globalised economy.
The State must go in the opposite direction. We need to double down on investment in knowledge, research, and people.
This Government understands what's at stake, it's right there in the programme for government. But in a time of growing economic uncertainty, we need to seize the initiative. Now is the moment to accelerate the delivery of these commitments.
We must ramp up science, technology, engineering, and mathematics participation across further and higher education, provide greater support for PhD and early-career researchers, and build stronger links between academia and industry.
That means formalising postdoctoral pathways, expanding graduate research funding, and sustaining growth through real collaboration.
We should also deepen EU research and innovation partnerships, especially for SMEs, because innovation shouldn't just happen in labs; it should power our entire economy.
This is how we transform our economy.
And while the benefits to the economy are compelling, we shouldn't overlook the personal upside.
PhD graduates enjoy a significant earnings premium, higher employment rates, and a diversity of career options. A recent Higher Education Authority analysis shows that doctoral graduates in the Republic enter the labour market successfully and maintain higher earnings for at least a decade post-graduation. Their skills are in demand both at home and abroad.
Roughly a third of Irish PhD graduates are working overseas seven years after graduation. While that might sound like brain drain, it's actually soft power. These graduates carry Irish research, values, and influence into global institutions.
And when they return, as many do, they enrich our research ecosystem with international experience, ideas, and networks.
It's time we recognised the true value of a doctorate. Not just as a title, but as a tool for building 's future.
Martin Daly is a Fianna Fáil TD for the Roscommon–Galway constituency
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Irish Independent
2 minutes ago
- Irish Independent
Tax group points out inconsistency in greenhouse gas taxes as farms escape cost
The group defends the carbon tax, which will rise again in the autumn budget, noting that revenues from it have been used to boost welfare payments and provide energy-efficiency supports for low-income households. It also notes that the tax – intended to discourage use of fossil fuels as the primary sources of greenhouse gas emissions – is not applied to the other primary source, methane. 'It should be noted that the vast majority of greenhouse gas emissions from agriculture (ie methane) are not subject to any environmental tax,' the group says in analysis presented to ministers. Farmers did have to pay carbon tax on fuel for agricultural vehicles but it was at a reduced rate, it said. 'Marked gas oil' - as agricultural diesel is categorised – currently costs 48 cents less per litre than regular diesel, it said. 'Farmers continue to be eligible for a double income tax relief,' the group said. 'A farmer may take an income tax or corporation tax deduction for farm diesel and then a further deduction for farm diesel which is equal to the difference between the carbon tax charged and the carbon tax that would have been charged had it been calculated at 2012 levels.' The tax paper also highlights different environmental taxes in other EU countries, including a new tax on livestock emissions announced in Denmark. Danish farmers will pay a tax of €40 per tonne of livestock methane emissions from 2030 which will increase to €100 by 2035. Revenues will help finance what the Danish parliament has described as the 'reorganisation' of the landscape with more focus on forestry and natural spaces. The Tax Strategy Group make no recommendations based on the proposal but flag research recently undertaken in Ireland around similar ideas. 'The Pathways project, funded by the European Climate Foundation, in partnership with the Institute of International & European Affairs, has published a series of papers on the future of the Irish Agri-food sector,' it says. 'Their paper on 'Agricultural Climate Policy in Ireland from 2030 to Net Zero' recommends Ireland establish an independent Emissions Pricing Design Commission, modelled on Denmark's expert group, to assess the feasibility and design of emissions pricing in Ireland's agricultural sector.'


RTÉ News
30 minutes ago
- RTÉ News
Parents call on HSE to make breakthrough peanut allergy treatment available
Parents of children with severe peanut allergies are calling on the HSE to make a breakthrough treatment available in Ireland. Palforzia is a medicine for treating peanut allergy in children from one to 17 years of age. It has been authorised for use in the EU by the European Medicines Agency, but currently there is no planned timeline to roll it out in Ireland. It works by gradually exposing children to higher doses of peanut to help lower the risk of severe reactions, including anaphylaxis. This method is called oral immunotherapy. There are more than 20,000 children in Ireland living with a severe peanut allergy. The current approach is to avoid peanuts in the diet and carry emergency medication in case they are eaten. Some parents are now taking their children, at their own expense, to the UK, US or other European countries to access the Palforzia treatment. Catherine Dolan, from Greystones in Co Wicklow, is among a group of parents who want the HSE to make Palforzia available here. Her six-year-old son has a severe peanut allergy that puts him at risk of anaphylaxis. Ms Dolan said it creates a great deal of anxiety as the family navigates daily interactions. She has considered accessing the treatment abroad but said the logistics are difficult. "We've always had healthcare in our own country, and it does pose a risk when you go outside of the Irish system. I would consider it, we are talking about it, but I'd be really, really cautious about it," she said. Ms Dolan said she feels it is unacceptable that the treatment is available under the NHS in the UK, and other European countries, but not here. "We need to know when, and why. It has to happen. I'm balanced in my view - I know the healthcare system is really stretched, but I know the consultants are there, the care is there, and the expertise is there. We just need a national plan now to roll it out," she said. The HSE said it makes decisions on which medicines are reimbursed by the taxpayer on "objective, scientific and economic grounds". In November 2023, the National Centre for Pharmacoeconomics made a recommendation to the HSE that Palforzia "not be considered for reimbursement unless cost-effectiveness can be improved relative to existing treatments". Professor of Paediatrics and Child Health in the Royal College of Surgeons in Ireland and Children's Health Ireland Dr Jonathan Hourihane said cost-effectiveness of medicines is usually calculated based on whether the amount of money needed to treat a condition can be recouped through demonstrated savings based on hospital bed use or emergency departments attendances. Dr Hourihane said this metric does not apply to peanut allergy. "This condition is a community-based disease characterised by anxiety and isolation, not by having to go to a hospital every two weeks. So, it's been unreasonably rejected. I think it's disappointing for us as a country, as a country that recruited children to get the licence for the product. And I think it's insulting to the families who have this condition," he said. Dr Hourihane said he attends international conferences and is told by allergy doctors that they are treating Irish children in the US, France, Italy and the UK, among others. He believes it is "a sign of desperation" that parents are willing to travel at their own expense for "care that they should be able to get locally". He added that Irish doctors are not supporting people to access treatment abroad because they are not involved in those programmes and cannot stand over them. Dr Hourihane said: "We are aware of children who've had to attend the emergency hospitals in Dublin having had allergic reactions during their treatment courses, and we don't know what they've reacted to because we're not involved. "So, I think it's putting doctors in allergy clinics in Ireland in a difficult position. They're having to treat children who are having complications of treatment being supervised remotely." Dr Hourihane believes the true impact of peanut allergies has been disregarded. He said: "It's not a trivial illness if you think your child might die tomorrow while you're at work. I think a fundamental problem with the way it's been evaluated is the impact hasn't been fully accepted in the way that families want it to be accepted. "As a clinician I find it frustrating and disappointing that the state-of-the-art treatments that we helped develop internationally [are not available here], and Ireland is a major international player in this area. We're now the laughing stock of the international allergy community." The HSE said the company that has applied to make Palforzia available through the HSE in Ireland has now paused the application until the end of this year. The HSE added that it "is committed to providing access to as many medicines as possible, in as timely a fashion as possible, from the resources available (provided) to it". "The HSE robustly assesses applications for pricing and reimbursement to make sure that it can stretch available resources as far as possible and to deliver the best value in relation to each medicine and ultimately more medicines to Irish citizens and patients," it said.


Irish Examiner
an hour ago
- Irish Examiner
The Mick Clifford Podcast: Unpacking the lacking National Development Plan with Louise Burne
The National Development Plan (NDP) review was launched earlier this week to an underwhelming response. An update of the previous plan, the review takes into account the Apple tax escrow fund the Government was eager not to claim, and promises a focus on providing infrastructure essential for housing delivery. Along with the Summer Economic Statement, both announcements this week make a statement about the forthcoming fiscal period, but without clarity on Trump's potential tariff plans—what does it all mean? Standing in for Mick this week, Opinion Editor Deirdre O'Shaughnessy speaks to Political Correspondent Louise Burne about the figures, the ambitions, and the lack of detail at the heart of the plan.